Hemab Therapeutics successfully completed its Nasdaq IPO, raising $346.7 million on May 1, 2026. The funds will support the development of treatments for rare blood clotting disorders.
Amount Raised
$347 Million
Round Type
IPO
CopenhagenBiotechnologyHealth CareTherapeuticsInvestors
Description
Hemab Therapeutics has concluded its IPO on Nasdaq, raising $346.7 million. This funding will advance its rare blood clotting treatments through clinical trials. Novo Holdings has been a significant supporter since the seed stage. Hemab's stock debuted strongly, closing nearly 90% higher on its first trading day.
Quick answer
Hemab Therapeutics raised $347 Million in a IPO round, dated June 1, 2026. Investors: Novo Holdings. Hemab Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
- How much did Hemab Therapeutics raise?
- Hemab Therapeutics raised $347 Million in a IPO round on June 1, 2026.
- Who invested in Hemab Therapeutics?
- Novo Holdings is named as investors in this round.
- What does Hemab Therapeutics do?
- Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
- Where is Hemab Therapeutics based and how big is it?
- Hemab Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark. Fundz records about 90 employees.
- Who are the decision-makers at Hemab Therapeutics?
- Fundz holds 2 contacts at Hemab Therapeutics, including the Senior Vice President, Development Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Hemab Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Georgiamune raised $93M on July 16, 2026.
- Crescent Biopharma raised $8.1M (Post-IPO Equity) on July 15, 2026.
- AdvanCell raised $315M (Series D) on July 15, 2026.
- Draig Therapeutics raised $65M (Series B) on July 14, 2026.
- Cue Biopharma raised $50M on July 13, 2026.
- Privo Technologies raised $1.2M (Grant) on July 12, 2026.
Who to call at Hemab Therapeutics, and when
A new round usually means Hemab Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Hemab Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hemab Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hemab Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hemab Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Hemab Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.